tumors and atherosclerosis, grading of fibrosis, and guidance of radiofrequency ablation.
Physics and Instrumentation
Acoustic radiation force is used to elicit an excitation response from tissue to obtain information on its characteristics. The force used originates from the transfer of momentum from the transmitted acoustic wave to the propagation medium. This momentum transfer results in the application of force in the direction of wave propagation. 1, 2, 10, 11 The magnitude of acoustic force is dependent on tissue properties and acoustic beam parameters. The mechanical properties of tissue are related to its response to ARFI excitation; softer tissues move further than stiffer tissues for a given force magnitude. 5, 6, 9 The region of excitation (ROE) is dictated by F = 2αI/c, where α is the attenuation coefficient, c is the speed of sound in the propagation medium, and I is the focal characteristics and intensity of the acoustic beam. [1] [2] [3] [4] [5] [6] 10, 11 Short-duration pulses are used to effectively portray the mechanical response of the tissue to this force. Pulses are typically less than 100 µs and displace soft tissue between 1 and 20 microns. Peak displacement is reached in less than 1 ms and has recovered to its original position within 5 ms. Images are taken of maximum tissue displacement through all time, the time it takes for tissue to reach its peak displacement, and tissue recovery time. 5, 6 
Thermal Safety
As with any form of ultrasonic imaging, ARFI carries the risk of tissue heating and cavitation. Due to the use of higher intensity pulses than conventional B-mode sonography, the safety of ARFI imaging has especially been an area of concern. As the transmitted beam travels through tissue, energy is transferred from the acoustic wave to the medium, causing tissue heating. However, because the acoustic pulses are applied for less than 1 ms, the amount of energy needed for the interrogation is relatively small and causes a temperature increase of less than 0.7°C, which is within the acceptable limit of a 1.0°C increase. Cavitation is more likely to occur with the use of lower frequencies and a mechanical index (MI) greater than the recommended limit of 1.9. 6, 8 Because ARFI uses higher frequencies that are comparable to those used in color Doppler imaging and an MI of less than 1.9, the possibility of cavitation is low. 6 
ARFI in Soft Tissue Imaging
Currently, sonography, magnetic resonance imaging (MRI), and computed tomography (CT) are considered the gold standards for soft tissue imaging. However, disadvantages to each method demonstrate the importance of developing a new imaging modality. Although CT and MRI are generally more sensitive than sonography for detecting soft tissue lesions, they both use contrast agents and are more costly. 2 Recently, several studies have focused on the clinical feasibility of ARFI imaging as an alternate method to the current techniques.
DIFFERENTIATION OF TISSUE LAYERS
These studies have established the superior capability of B-mode sonography over ARFI in differentiating tissue layers. 7,10 Although the cardiovascular system and gastrointestinal (GI) tract are functionally very different, they are both composed of multilayered structures. The ability to distinguish between each layer is very important in both systems because of the health issues related to each.
Atherosclerosis accounts for approximately 41% of deaths in the United States and is characterized by the hardening and thickening of the arteries due to depositions of calcium and fat in the inner arterial layers. Generally, clinical symptoms are not seen until the arteries are severely narrowed or stroke-inducing clots are produced and are preceded by changes in the mechanical properties of the vessels. 10 ARFI is able to identify these changes, making it a useful tool for the early detection and evaluation of vascular disease.
Although different issues are encountered in the GI tract, it is equally important to distinguish between tissue layers. GI cancers are staged by the degree of tumor invasion into the bowel wall. The most critical staging distinction is made between uT2 and uT3 tumors; uT2 tumors have not penetrated through the muscularis propria, whereas uT3 tumors have. This distinction determines whether the patient will undergo local tumor excision for a uT2 tumor or chemotherapy and radiation, followed by radical resection to treat a uT3 tumor. Because the latter is associated with greater risks, it is vital that the tumors be staged correctly. Currently, endoscopic sonography is used to image potentially malignant masses of the GI tract, but it can be inaccurate and staging of uT2 lesions as uT3 occurs in approximately 10% to 35% of endoscopic sonography scans. Palmeri et al. 7 found that ARFI showed improved delineation of gastric tissue layers and clearer boundaries of colonic tumors.
BREAST LESIONS
Studies on breast masses have found that ARFI is able to make distinctions between malignancies, benign fibroadenomas, and cysts. Malignant masses appear larger with greater contrast in ARFI images than in corresponding B-mode images and also have slower recovery times than healthy tissue in some cases. The size difference is attributed to the tumor radiating outward and infiltrating surrounding tissue, serving to anchor the lesion and subsequently stiffen the tissue. Benign fibroadenomas and cysts appear similar in size in both ARFI and B-mode images. Fibroadenomas vary in displacement, appearing either stiffer or softer than surrounding tissue, whereas cysts appear softer than surrounding tissues, sometimes containing "salt-and-pepper" noise. This is caused by acoustic streaming within the cyst in response to ARFI excitation. In a recent blind study, a radiologist was able to correctly identify almost all of the masses presented in ARFI images as malignant or benign with increased clinical confidence. 9
ARFI IN ABDOMINAL IMAGING
Improved visualization of malignant masses was also noted in ARFI interrogation of liver and kidney tissue, along with the capability to diagnose the extent of fibrosis. The grading of fibrosis is significant because of the increased incidence of hepatocellular carcinoma (HCC) in cirrhotic livers and the association between fibrosis and chronic rejection of transplant kidneys. 2, 12 Cirrhotic liver and kidney tissue appears to be significantly stiffer than healthy liver and kidney tissue. 2, 12, 13 Studies have also revealed that ARFI is capable of visualizing boundary definition and lesion contrast relative to surrounding nontumorous tissue with greater clarity than B-mode sonography. 2, 13 In one such study, data was acquired from patients already referred for image guided-biopsy or ablation of abdominal lesions. All the images obtained during the experiment showed the same results: the target mass was visualized with greater contrast and improved boundary definition using ARFI than it was with B-mode sonography. Primary tumors appeared softer than surrounding regional liver, whereas secondary tumors appeared stiffer than surrounding tissue. A general summary of results is illustrated in Figures 1 and 2 . Figure 1a ,b shows matched B-mode and ARFI images, respectively, of liver metastasis in one patient, likely originating from pancreatic cancer. Clear boundaries are hard to distinguish in the B-mode image, whereas the edges of the lesion are better visualized with ARFI. The mass is seen as an area of low displacement (outlined by white arrows). Two additional metastases were also found incidentally in the ARFI image, indicated by black arrows. This corresponds to the CT image shown in Figure 1c , which shows widespread liver metastasis. Figure 2a,b shows B-mode and ARFI images acquired of a metastatic adrenal cortical carcinoma located in the left lobe of the liver. As in Figures 1a and 2b, Figure 2a shows a B-mode image with poor visualization of the lesion, whereas in Figure 2b , clear boundaries are identified with ARFI. 13
Guidance of Radiofrequency Ablation Procedures
Radiofrequency (RF) ablation is a widely used method for treating liver malignancies, as well as rapid or irregular heartbeats. 1, 3 RF ablation uses radiofrequency currents to generate heat and subsequently destroy the target tissue thermally. 1 The procedure is guided using sonography to visualize electrode placement and lesion growth. However, in many patients, target tissues are inadequately visualized, and B-mode imaging of lesion development can produce inconsistent results. 1, 3 Because the lesions produced during the ablation procedure are associated with a >4 times increase in stiffness compared to untreated tissue, the feasibility of using ARFI as a tool for monitoring has been investigated by several groups. 4 
CARDIAC ABLATION
One study compared intracardiac echocardiography (ICE) and ARFI imaging, examining their ability to monitor the development of thermal lesions within the right atrium of the heart. To reduce cardiac motion artifact, the researchers used electrocardiogram (ECG) triggering, allowing images to be acquired late in diastole when there is the least motion in the heart. The ablation procedure was performed and imaged at three separate sites using a Siemens SONOLINE Antares scanner in combination with an AcuNav intracardiac phasedarray probe and an ablation catheter. At two out of the three locations, B-mode sonography indicated little to no change in tissue postablation, whereas ARFI imaging identified areas of decreased displacement corresponding to images from pathology. Figure 3 shows the third ablation site within the right atrium, only a few millimeters away from the second site. In the reference B-mode image, a section of the ablation catheter can be seen as an echogenic area on the left side of the image. The ARFI reference image shows a stiffer area on the left side and softer tissue on the right side of the image. B-mode images taken after the procedure show little change, whereas the ARFI image shows a new region of stiffness on the right side. The average maximum displacement in this area went from 4.09 µm preablation to 2.55 µm postablation. Images from pathology correspond to the lesions visualized with ARFI and support the theory that the stiff tissue seen on the left is in fact the lesion created during the second ablation. 3 The displacements in the left, center, and right sections of Figure 3 are shown in Table 1 .
Hsu et al. 3 were able to demonstrate the feasibility of using ARFI imaging in RF ablation procedure guidance, but there were some challenges encountered involving placement of the imaging catheter. This resulted in the inability to consistently evaluate lesion development accurately and suggests the need for a system ensuring correct placement of the imaging catheter.
LIVER ABLATION
ARFI imaging is also being investigated for its potential role in liver ablation guidance. Increasing popularity of the use of minimally invasive ablation procedures for treating malignancies in regions such as the breast, liver, kidney, and prostate necessitates the development of an effective and cost-efficient method to guide these procedures. CT and MRI are the current standards for assessing ablation procedures, but early postoperative tissue response such as reactive hyperemia may cause the appearance of residual tumor. To avoid misinterpretation, assessment images are taken weeks after the initial procedure. This prevents the physician from obtaining vital information on lesion development during the procedure, increasing risk to the patient's health and the overall success of the ablation. Conventional sonography is capable of demonstrating morphological change but can be inconsistent and does not readily indicate lesion size, location, and boundaries. 1 Typically, RF ablation procedures are terminated when the tissue surrounding the catheter becomes highly echogenic. This increase in echogenicity occurs because of tissue "boiling" and the formation of bubbles, which is associated with tissue necrosis. However, this is not an accurate measurement of lesion size because necrosis can occur without the presence of considerable bubble formation, in which case sonography may not demonstrate the full extent of lesion development. 4 In a series of in vitro and in vivo experiments, Fahey et al. 1, 4 examined matched B-mode and ARFI images of postablation liver tissue. Data was acquired with a Siemens SONOLINE Antares scanner and a CH6-2 curvilinear transducer operating at 2.5 MHz. Freshly excised bovine livers were used for in vitro procedures, whereas ovine livers were used for the in vivo ablations. Figure 4 shows matched B-mode and ARFI images taken 90 seconds after ablation. Although the B-mode image indicates little to no change in the target tissue, an area of increased stiffness is clearly visualized in the ARFI image, whereas prior to the procedure, there had been softer tissue present. These findings were consistent in both sets of in vitro results, and although there was a noticeable increase in echogenicity in the second postablation B-mode image taken, accurate information on lesion size, location, and boundaries could still not be inferred. ARFI images, on the other hand, were able to distinguish clear borders on all sides of the lesions, with the exception of the distal edge, which was obscured by the presence of the ablation electrode cluster.
In vivo experiments yielded similar results, with B-mode images showing subtle changes in echogenicity and ARFI images demonstrating a large area FIGURE 3. B-mode and acoustic radiation force impulse (ARFI) images of the second and third ablation sites within the right atrium. The B-mode image (a), taken before the third ablation, shows the right atrium sloping downward from right to left. The corresponding ARFI image (b), showing displacements in µm away from the transducer, displays a region of tissue on the left that displaces less than the adjacent tissue. It is believed that this is the lesion created during the second ablation. After ablating at the third site, the B-mode image (c) shows little change. The ARFI image (d) shows an additional region that displaces less on the right side of the image. A narrow strip of soft tissue that displaces more than the surrounding tissue remains. It is believed that this indicates the creation of side-by-side lesions separated by 1 mm. Arrows mark the position of the newly formed lesion in both the postablation B-mode and ARFI images. of increased stiffness with the average maximum displacement measuring 1.5 µm. ARFI reference images show fairly uniform stiffness throughout the hepatic tissue, measuring displacements of around 3.5 to 5 µm by the applied radiation force. In comparison with the postablation B-mode image, the ARFI image shows a large region of reduced displacement measuring 1.5 µm versus the 3.5-to 5-µm preablation corresponding to the images taken by pathology. There were slight discrepancies in measurements, though, with the lesion measuring 3 cm in the pathology photo and 2.5 cm in the ARFI image. This was probably due to imprecisely aligned tissue planes. 1 
Conclusion
Current "gold-standard" methods of diagnostic imaging have played a vital role in evaluating the health of soft tissue, but disadvantages associated with each have prompted the investigation of new imaging techniques. Although research is ongoing, several groups have already demonstrated the clinical feasibility of using ARFI in a variety of clinical applications. When used in combination with B-mode sonography, ARFI is capable of producing images that provide improved diagnostic information over conventional sonography alone. These studies suggest that although there remain challenges to be worked through, ARFI has the potential to be a valuable imaging tool for assessing tissue health and ultimately for improving patient care.
